Results 61 to 70 of about 274,722 (228)

Recent advances in food allergy [PDF]

open access: yes, 2016
Food allergy is a public health issue that has significantly increased worldwide in the past decade, affecting consumers’ quality of life and making increasing demands on health service resources.
Anagnostou K.   +55 more
core   +1 more source

Active treatment for food allergy

open access: yesAllergology International, 2016
Food allergy has grown in rapidly in prevalence, currently affecting 5% of adults and 8% of children. Management strategy is currently limited to 1) food avoidance and 2) carrying and using rescue intramuscular epinephrine/adrenaline and oral ...
Aaron K. Kobernick, A. Wesley Burks
doaj   +1 more source

Diagnosing and Treating Food Allergy [PDF]

open access: yes, 2013
t Food allergy (FA) is defined as an abnormal immunological reaction to food proteins. Over 90 % of FAs in childhood are caused by eight foods: cow’s milk, hen’s egg, soy, peanuts, tree nuts, wheat, fish and shellfish.
AITORO, ROSITA   +9 more
core   +1 more source

Managing food allergy: GA2LEN guideline 2022

open access: yesWorld Allergy Organization Journal, 2022
Food allergy affects approximately 2–4% of children and adults. This guideline provides recommendations for managing food allergy from the Global Allergy and Asthma European Network (GA2LEN).
Antonella Muraro, MD   +81 more
doaj   +1 more source

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).

open access: yesJournal of Allergy and Clinical Immunology: In Practice
BACKGROUND Due to limited treatment options for peanut allergy, patients remain at risk for allergic reactions due to accidental exposure. Epicutaneous immunotherapy (EPIT) is a novel treatment being investigated for peanut allergy.
J. Pongracic   +33 more
semanticscholar   +1 more source

International consensus on (ICON) anaphylaxis [PDF]

open access: yes, 2014
ICON: Anaphylaxis provides a unique perspective on the principal evidence-based anaphylaxis guidelines developed and published independently from 2010 through 2014 by four allergy/immunology organizations.
Alvarez-Twose   +137 more
core   +3 more sources

Epicutaneous immunotherapy protects cashew sensitized mice from anaphylaxis [PDF]

open access: yes, 2020
Background: The prevalence of tree nut allergy has increased worldwide, and cashew has become one of the most common food allergens. More critically, cashew allergy is frequently associated with severe anaphylaxis. Despite the high medical need, no approved treatment is available and strict avoidance and preparedness for prompt treatment of allergic ...
Benjamin Pelletier   +13 more
openaire   +1 more source

Current developments in the treatment of peanut allergy [PDF]

open access: yes, 2021
Peanut allergy is a potentially life-threatening disease because it leads to severe allergic reactions, especially in children but also in adults. So far, allergen avoidance is the most effective therapy for treating peanut allergy.
Alexiou, Aikaterina   +4 more
core   +1 more source

Layer-by-Layer-Assembled Multilayer Films for Transcutaneous Drug and Vaccine Delivery [PDF]

open access: yes, 2009
We describe protein- and oligonucleotide-loaded layer-by-layer (LbL)-assembled multilayer films incorporating a hydrolytically degradable polymer for transcutaneous drug or vaccine delivery.
Hammond, Paula T   +4 more
core   +1 more source

Food allergies: Novel mechanisms and therapeutic perspectives [PDF]

open access: yes, 2016
Childhood food allergy (FA) rates have rapidly increased with significant direct medical costs for the health care system and even larger costs for the families with a food-allergic child.
AITORO, ROSITA   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy